期刊文献+

慢性髓性白血病bcr-abl融合基因的克隆与表达 被引量:3

CLONING AND EXPRESSION OF CML bcr-abl FUSION GENE FRAGMENT
下载PDF
导出
摘要 以慢性髓性白血病K562细胞总RNA为模板,采用RT PCR技术扩增包含bcr abl融合位点周围的基因片段,定向克隆到pGEX 6P 1载体谷光甘肽S转移酶(GST)的下游。将重组质粒转化大肠杆菌BL21菌株,以1.0mmol·L-1IPTG诱导bcr abl融合基因片段的表达,其产物经聚丙烯酰胺凝胶电泳鉴定,结果证实该融合蛋白分子质量约42ku。用该表达产物免疫ICR小鼠,所制备的抗血清可与K562细胞中特异性抗原反应,表明该bcr abl/GST融合蛋白具有bcr abl基因产物的特异抗原性。 The 450 bp of bcr\|abl fusion gene was amplified from total RNA of K562 cells by RT\|PCR and was cloned into the downstream of GST gene in pGEX\|6P\|1 vector. The recombinant vector was transformed into E.coli BL21 cell for expression. The size of fusion protein was 42 ku which identified by SDS\|PAGE. The ICR mice were immunized with the fusion protein. The anti\|serum could bind P210bcr\|abl in K562 cells in IFA, this results suggested that the fusion protein had specific antigenicity of P210bcr\|abl.
出处 《扬州大学学报(农业与生命科学版)》 CAS CSCD 2003年第2期21-23,39,共4页 Journal of Yangzhou University:Agricultural and Life Science Edition
基金 江苏省高校自然科学基金项目(K0109138)
关键词 慢性髓性白血病.bcr—abl融合基因 克隆 表达 CML bcr\|abl fusion gene cloning expression
  • 相关文献

参考文献2

二级参考文献5

共引文献16

同被引文献18

  • 1姜扬文,钱莉,刘伟,龚卫娟,万兵,管俊,季明春.稳定表达bcr-abl融合基因片段的鼠SP2/0细胞系的建立[J].中国实验血液学杂志,2005,13(4):601-604. 被引量:4
  • 2Verfaillie C M,Scott M R.Gene therapy for chronic myelogenous leukemia[J].Molecular Medicine Today,1999(5):359-361.
  • 3Sin J I,Kim J,Patchuk C.Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo[J].Clin Diagn Lab Immunol,2000,7(5):751-758.
  • 4Kantarjian H M,Deisseroth A,Kurzrock R,et al.Chronic myelogenous leukemia:Concise update[J].Blood,1993,82(3):691-692.
  • 5Wetzler M,Talpax M,Van Etten R A,et al.Supercellular localization of bcr,abl,and bcr-abl protein in normal and leukemia cells and correlation of expression with myeloid differentiation[J].J Clin Invest,1993,92(1):19-25.
  • 6Tauchi T,Yoshimura A.CIS1,a cytokine-inducible SH2 protein,suppresses bcr/abl-mediated transfor-mation:Involvement of the ubiquitin proteasome pathway.experimenta[J].Hematology,2001,29(3):356-361.
  • 7Bertagnolli M,Herrmann S.IL-7 supports the generation of cytotoxic T lymphocytes from thymocytes:Multiple lymphokines required for proliferation and immunol[J].Cytotoxicity,1990,145(6):1706-1712.
  • 8Weidmann E, Brieger J, Jahn B, et al. Lactate dehydragenaserelease assay: a reliable nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lyric activity against blasts from acute myelocytic leukemia. Ann Hematol, 1995, 70: 153-158.
  • 9Schwartz J, Pinilla-Ibarz J, Yuan RR, et al. Novel targeted and immunotherapeutic strategies in chronic myeloid leukemia. Semin Hematol, 2003, 40 : 87-96.
  • 10Giralt S, Hester J, Huh Y, et al. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood, 1995, 86: 4337-4343.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部